• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Clinical Challenges in Hypertension I - Product Image

Clinical Challenges in Hypertension I

  • ID: 1408445
  • November 2009
  • 160 Pages
  • Clinical Publishing

This book takes an innovative new approach to therapeutic decision-making, providing answers to a range of questions that the busy clinician faces on a daily basis. In a carefully chosen series of discussions, the contributors, all of whom are internationally recognised authorities in their fields, offer their own recommendations for managing difficult problems and offer insights into the value or otherwise of various treatment choices based on their own experience and the available evidence.


- Addresses practical questions not covered in current guidelines
- Provides treatment recommendations based on hands-on clinical experience at major centres of excellence
- Aids the physician in prescribing for the hypertensive patient presenting with challenging conditions


- Specialists in hypertension and renal medicine
- Cardiologists
- General physicians
- Hospital pharmacists

Note: Product cover images may vary from those shown

Editors and Contributors

1. What is endothelial cell dysfunction and does it impact capacity for vasodilatation?
P. P. Toth

2. Sleep disorders and hypertension
C. C. Gonzaga, D. A. Calhoun

3. Treatment of early morning surges in blood pressure
K. Kario

4. Use of out-of-office blood pressure monitoring versus office-based measurements for managing patients with hypertension
N. Ghuman, W. B. White

5. Is blood pressure control more important than decreasing activity in the renin-angiotensin axis?
W. J. Elliott

6. Is there a class effect for all angiotensin-converting enzyme inhibitors when evaluating end-organ protection?
P. P. Toth, D. Sica

7. Are angiotensin-receptor blockers equivalent or superior to ACE inhibitors relative to blood pressure control and/or end-organ protection?
R. R. Townsend

8. Treatment of hypertension in the post-stroke patient in both the acute and chronic setting
W. J. Elliott

9. Isolated systolic hypertension and management of hypertension in the very elderly
S. S. Franklin

10. Management of hypertension in patients with coronary artery disease
C. Rosendorff

List of abbreviations

Note: Product cover images may vary from those shown

Edited by:

- DA Sica, Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University Health System, Richmond, Virginia, USA
- PP Toth, University of Illinois College of Medicine, Peoria, and Southern Illinois University School of Medicine, Springfield, Illinois, USA.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown



Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S